42388-013Level 3
COMETRIQ (cabozantinib)
**Product type:** Human Prescription Drug
**Active ingredient:** CABOZANTINIB S-MALATE
**Strength:** 20 mg/1
**Dosage form:** Capsule
**Route:** Oral
**Labeler:** Exelixis, Inc.
**Marketing category:** NDA (NDA203756)
**Pharmacologic class:** Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/42388-013Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.